Gennex Laboratories Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|
| Revenue | 27.90 | 26.15 | 27.35 |
| Operating Expense | 22.26 | 23.21 | 21.78 |
| Net Profit | 4.15 | 1.50 | 4.21 |
| Net Profit Margin | 14.87 | 5.74 | 15.39 |
| Earning Per Share | 0.18 | 0.07 | 0.19 |
| EBIDTA | 5.64 | 2.88 | 5.57 |
| Effective Tax Rate | 12.41 | 21.09 | 13.49 |
| Particulars | Jun 2025 |
|---|---|
| Revenue | 27.90 |
| Operating Expense | 22.26 |
| Net Profit | 4.15 |
| Net Profit Margin | 14.87 |
| Earning Per Share | 0.18 |
| EBIDTA | 5.64 |
| Effective Tax Rate | 12.41 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Total Revenue Annual | 94.58 | 66.80 | 65.10 |
| Operating Expenses Annual | 84.23 | 54.38 | 60.52 |
| Operating Profit Annual | 19.42 | 16.72 | 7.99 |
| Interest Annual | 1.58 | 1.16 | 1.23 |
| Depreciation | 0.77 | 0.81 | 0.74 |
| Net Profit Annual | 14.04 | 11.80 | 4.56 |
| Tax Annual | 3.02 | 2.96 | 1.45 |
| Particulars | Mar 2025 |
|---|---|
| Total Revenue Annual | 94.58 |
| Operating Expenses Annual | 84.23 |
| Operating Profit Annual | 19.42 |
| Interest Annual | 1.58 |
| Depreciation | 0.77 |
| Net Profit Annual | 14.04 |
| Tax Annual | 3.02 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Cash Flow at the Beginning | 60.96 | 14.45 | 8.31 |
| Cash Flow from Operations | -9.52 | -33.43 | -14.45 |
| Cash Flow from Investing | 2.63 | 0.93 | -0.77 |
| Cash Flow from Financing | 1.53 | 79.01 | 21.35 |
| Cash Flow at the End | 55.60 | 60.96 | 14.45 |
| Particulars | Mar 2025 |
|---|---|
| Cash Flow at the Beginning | 60.96 |
| Cash Flow from Operations | -9.52 |
| Cash Flow from Investing | 2.63 |
| Cash Flow from Financing | 1.53 |
| Cash Flow at the End | 55.60 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| PBDIT Margin (%) | 18.47 | 22.59 | 11.20 |
| PBIT Margin (%) | 17.73 | 21.50 | 10.16 |
| PBT Margin (%) | 6.50 | 2.97 | 1.90 |
| Net PROFIT Margin (%) | 13.36 | 15.94 | 6.39 |
| Return On Networth / Equity (%) | 7.90 | 9.45 | 7.41 |
| Return On Networth /Employed (%) | 10.25 | 12.50 | 10.69 |
| Return On Assets (%) | 7.75 | 9.24 | 6.71 |
| Total Debt / Equity (X) | 0.01 | 0.01 | 0.09 |
| Asset Turnover Ratio (%) | 0.58 | 0.58 | 1.05 |
| Particulars | Mar 2025 |
|---|---|
| PBDIT Margin (%) | 18.47 |
| PBIT Margin (%) | 17.73 |
| PBT Margin (%) | 6.50 |
| Net PROFIT Margin (%) | 13.36 |
| Return On Networth / Equity (%) | 7.90 |
| Return On Networth /Employed (%) | 10.25 |
| Return On Assets (%) | 7.75 |
| Total Debt / Equity (X) | 0.01 |
| Asset Turnover Ratio (%) | 0.58 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|
| Fixed Assets Annual | 19.65 | 15.83 | 15.18 |
| Total Current Assets Annual | 187.02 | 178.99 | 72.16 |
| Non Current Assets Annual | 31.36 | 26.35 | 24.06 |
| Total Shareholders Funds Annual | 184.80 | 170.76 | 79.02 |
| Total Assets Annual | 218.38 | 205.34 | 96.22 |
| Particulars | Mar 2025 |
|---|---|
| Fixed Assets Annual | 19.65 |
| Total Current Assets Annual | 187.02 |
| Non Current Assets Annual | 31.36 |
| Total Shareholders Funds Annual | 184.80 |
| Total Assets Annual | 218.38 |
EPS (INR)
Expected
0.20
Reported
0.22
Surprise
10.00%
Mar 2025
EPS beaten by 10.00%
Dec 2024
EPS beaten by 40.00%
Sep 2024
EPS beaten by 10.00%
